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Abstract
Although rarely, Arcobacter spp. have been associated with diarrhoea and bacteraemia. We report a persistent case in a healthy 26-year-old
Spanish male of bloody diarrhoea, which was attributed to Campylobacter but in fact was caused by Arcobacter cryaerophilus, as determined by
sequencing of the rpoB gene. The isolate was re-identified by matrix-assisted laser desorption ionization time of flight (MALDI-TOF) and
genotyped for five putative virulence genes and for seven genes included in the Arcobacter multilocus sequence typing database. The low
score obtained by MALDI-TOF indicates the need to complement the database with more isolates. Only the ciaB gene, which encodes for
an invasin, was detected. Despite the isolate belonging to a new sequence type, three of the alleles (glnA, pgm and tkt) had been found
previously in isolates from faeces of patients with diarrhoea. This study, together with the reviewed literature, indicates that Arcobacter can
produce bacteraemia and that the isolation from patients with diarrhoea range from 0.11% to 1.25%. This study also demonstrates that
Arcobacter species are confused with Campylobacter spp., as previously suggested. This is one of the factors that leads to underestimation of
their incidence together with the use of inappropriate detection and identification methods.
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Introduction
Bacteria of the genus Arcobacter, which was created with
aerotolerant species previously included in the genus Cam-
pylobacter, are considered emergent enteropathogens and
potential zoonotic agents [1]. The genus currently includes 17
species and some of these species produce abortions, mastitis
and gastrointestinal disorders in animals [2–5] and bactera-
emia, endocarditis, peritonitis and diarrhoea in humans [6–12].
So far there have been very few human diarrhoea cases
reported despite it having been found that Arcobacter butzleri
was the fourth most common Campylobacter-like organism
isolated from human stools [1,13,14]. Persistent watery
diarrhoea was the main symptom associated with Arcobacter
species, in contrast to the bloody diarrhoea produced by
Campylobacter jejuni [1,13]. It has been suggested that Cam-
pylobacter isolates cover Arcobacter spp. [13], which are not
routinely studied with the ad hoc methods in clinical labora-
tories. However, the true impact of this confusion is unknown
[1].
This study describes in detail the clinical characteristics of
an acute case of diarrhoea produced by A. cryaerophilus, which
was recognized after sequencing of the rpoB gene from an
isolate biochemically identified as Campylobacter sp. The isolate
was re-identified with matrix-assisted laser desorption ioniza-
tion time of flight (MALDI-TOF) and genotyped by multilocus
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sequence typing; its putative virulence genotype was screened
by PCR. The study intends to alert clinicians to the possible
role that this poorly known bacteria genus plays in the
development of human disease by showing all known clinical
cases.
Case Report
A 26-year-old male with no previous history of disease visited
the doctor complaining of bloody watery diarrhoea of 3 weeks
duration (with about three liquid depositions a day), with
abdominal pain but without fever, nausea or vomiting. The
patient had been seen with similar symptoms 4 months before
and was diagnosed with acute gastroenteritis. A stringent diet
was the recommended treatment but no laboratory testing
was made at that time. Considering this previous history, a
blood and stool analysis was carried out. The stool sample was
examined for parasites and cultured for Escherichia coli,
Salmonella spp., Shigella spp., Yersinia enterocolitica, Aeromonas
spp., Plesiomonas spp., Vibrio spp. and Campylobacter spp.
Complete blood count was performed and searches were
made for hepatitis B antigen, anti-hepatitis C virus antibody
and other antibodies against human immunodeficiency virus,
cytomegalovirus, adenoviruses and parvovirus B19. The
patient was diagnosed with acute gastroenteritis and an
empirical antibiotic treatment was initiated with amoxicillin/
clavulanic acid.
The laboratory evaluation showed an almost normal
complete blood count, except for a slight relative reduction
in neutrophils (37%) and an increase in lymphocytes (51.2%).
The blood culture was negative but the stool sample showed a
positive culture in Campylosel medium (BioMerieux, Marcy
l’Etoile, France) after 3 days of incubation at 42°C, under
microaerobic conditions. The colonies were identified as
Campylobacter sp. based on phenotypic tests (Gram stain,
hippurate hydrolysis and resistance to cephalothin). By disc
diffusion, the isolate was susceptible to amoxicillin/clavulanic
acid and to gentamicin, but was resistant to ciprofloxacin and
erythromycin. Considering these results and the good evolu-
tion of the patient, the empirical treatment was maintained for
8 days, after which time he had recovered completely with no
more diarrhoea episodes. The isolate was sent to the Unit of
Microbiology at the University Rovira i Virgili for re-identifi-
cation using the sequences of the rpoB, as was done routinely
for all isolates identified as Campylobacter at the hospital. The
DNA extraction, amplification and sequencing were
performed using primers and conditions previously described
[15]. A BlastN analysis with the obtained rpoB sequence
revealed a 99% similarity with the strain of A. cryaerophilus
(Strain of subgroup 1B, LMG 10229, accession number
EU669900), followed by a 95% similarity with the sequence
of the type strain of A. cryaerophilus (Strain of subgroup 1A,
LMG 9904T, accession number EU669899), and only 90%
similarity with a strain of the next most similar species,
A. butzleri (Strain ED-1, accession number AP012047). There-
fore, the isolate was identified as being A. cryaerophilus.
Considering the rarity of the recovered bacterium, the
patient was contacted again to obtain additional information.
He indicated that he regularly eats raw meat and fish, and also
had a dog at home and a group of laying hens fenced in the
garden. Despite the patient indicating that he had not had any
other episodes of diarrhoea, a new stool sample was taken to
evaluate his possible carrier state. Rectal samples from the dog
and cloacal swab samples from three of the six laying hens he
had at that time, as well as two samples of their faeces
collected from the ground, were taken for microbiological
examination using molecular detection and culture, as
described in a previous study [16]. However, all of these
samples were negative for Arcobacter.
To our knowledge, only three cases of A. cryaerophilus
infection have so far been reported [6,17,18]. Those cases,
together with the few available for the other species of the
genus, are summarized in Tables 1 and 2. The first and only
case of diarrhoea due to A. cryaerophilus dates back to 1988
when it was still included in the genus Campylobacter with the
name Campylobacter cryaerophila. The 35-year-old homosexual
man with this infection showed intermittent diarrhoea of 4–
6 months duration with abdominal pain [17]. The other two
are cases of bacteraemia, one in Taiwan that involved an
immunocompromised 72-year-old woman with uraemia who
showed a haematogenous pneumonia [18], and the other in a
7-year-old boy from China who had fallen into a mud pool
while driving a mini motorcycle and suffocated [6]. As seen in
Tables 1 and 2, a few other cases of diarrhoea and bacteraemia
have been linked to A. butzleri [4,7,19–23] and, more rarely, to
Arcobacter skirrowii [24]. For instance, a case of acute diarrhoea
caused by A. butzleri in a 30-year-old healthy man was reported
from Turkey; it was cured with treatment with ciprofloxacin
[23]. A recent case of peritonitis due to Arcobacter sp. has been
reported in a peritoneal dialysis patient whose catheter was
repositioned [25]. Despite intravenous cefazolin and oral
levofloxacin being given as a prophylaxis, the patient only
responded after intravenous ticarcillin–clavulanate treatment
for 2 weeks, with no need for the catheter to be removed.
The majority of these case studies underline the difficulty in
recognizing or identifying these bacteria because they grew
slowly and their identification required sequencing of the
16S rRNA gene [6,7,21] or the use of specific multiplex
PCR methods [22–24,26]. Considering that several hospitals
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now use the MALDI-TOF identification technique for such
fastidious, slow-growing microbes, we have re-identified our
A. cryaerophilus isolate using that method [27]. The isolate was
studied with the Ultraflex TOF/TOF MALDI-TOF instrument,
that uses the MALDI BIOTYPER 2.0 software (Bruker Daltonics,
Bremen, Germany) after spotting a fresh colony directly on to
the target plate and the addition of 1 lL of the matrix,
cinaminic acid, as described by the manufacturer. The type
strain of A. cryaerophilus (LMG 9904T) was used in parallel as a
control. The MALDI BIOTYPER output for our clinical strain
scored 1.493 with the strain A. cryaerophilus T277 CPB. A
score of <1.7 normally indicates an unconfident identification,
between 1.7 and 1.99 indicates a genus-level identification, and
a score ≥2 indicates a species-level identification. The second
higher score was only 1.42 with a strain of the species
Pseudomonas proteolytica. Despite the unconfident identification
the first match was with an A. cryaerophilus and among the
following bacteria listed there was no Campylobacter spp. The
type strain of A. cryaerophilus (LMG 9904T) used as control was
correctly identified despite it showing a low score (1.885).
Clinicians should be aware that in the case of a strain showing
this behaviour with MALDI-TOF it is worth confirming its
identity by sequencing the rpoB gene, so that the true incidence
of these bacteria can be established. The inconclusive results
obtained with MALDI-TOF could be explained by the fact that
a correct identification with this method depends on the
number of bacteria strains included in the database [27]. The
BIOTYPER database has only 13 Arcobacter strains and only four
of them belong to the species A. cryaerophilus. However, the
capacity of this method to separate strains belonging to all
TABLE 1. Cases of intestinal infections associated with Arcobacter spp.
Patients’
sex/age Country Presentation Species Outcome Underlying conditions Reference
M/35 years Australia Chronic diarrhoea (6 months) A. cryaerophilus1 NS Homosexual with history
of anxiety and repeated
sexual exposure
[17]
3–7 years2 Italy No diarrhoea, abdominal pain,
occasional vomiting or fever
A. butzleri Recovered 7–10 days after
no specific treatment
None [4]
1. M/48 years
2. F/52 years
Germany 1. Acute watery diarrhoea (15 days)
and abdominal cramps
2. Chronic diarrhoea (3 weeks)
and abdominal cramps
A. butzleri 1. Recovered 3 days after
treatment with ofloxacin
2. Recovered 2 days after
treatment with doxycycline
1. Type 1 diabetes mellitus
2. Hyperuricaemia
and alcohol abuse
[19]
1. M/2 years
2. F/1 years
Chile 1. Acute mucous diarrhoea
and vomiting
2. Chronic diarrhoea (4
months) with abdominal
cramps and pain
A. butzleri 1. Recovered in 2 days with
parenteral fluid therapy, restricted
diet but without
antimicrobial treatment
2. Recovered 10 days after treatment
with erythromycin
None [22]
M/73 years Belgium Chronic diarrhoea (2 months) A. skirrowii Recovered 10 days after no
specific treatment
Prosthetic aortic
heart valve
[24]
M/30 years Turkey Acute watery diarrhoea, abdominal
pain, nausea and sweating
A. butzleri Recovered 2 days after treatment
with ciprofloxacin
None [23]
M/26 years Spain Persistent bloody and watery
diarrhoea (3 weeks)
A. cryaerophilus Recovered 8 days after treatment with
amoxicillin/clavulanic acid
Acute gastroenteritis
4 months earlier
Current study
NS, not specified.
1Originally described as Campylobacter cryaerophila.
2Four males and six females between 3 and 7 years old.
TABLE 2. Extra-intestinal infections associated with Arcobacter spp.
Patients
sex/age Country Presentation Species Outcome Underlying disease Reference
Neonate UK Bacteraemia with hypotension,
hypothermia and hypoglycaemia
A. butzleri Recovered 6 days after penicillin
and cefotaxime treatment
Mother had prenatal bleeding due to
placenta praevia. Delivery at 26
weeks of gestation
[20]
M/72 years Taiwan Bacteraemia and
haematogenous
pneumonia
A. cryaerophilus Recovered 2 weeks
after ceftizoxime
and tobramycin treatment
Chronic renal failure, haemodialysis with
arteriovenous fistula. Two months of
fever and progressive cough with
purulent sputum. She also had a 1-month
history of anorexia and frequent loose
stool 2 months before admission
[18]
M/60 years Taiwan Bacteraemia with fever
and haematemesis
A. butzleri Recovered 4 days after
cefuroxime treatment
Chronic hepatitis B carrier,
liver cirrhosis
[21]
F/69 years Hong Kong Bacteraemia with fever and
lower quadrant pain
A. butzleri Recovered 3 days after
cefuroxime
and metronidazole treatment
Gangrenous appendicitis [7]
F/63 years China Peritonitis after repositioning of
catheter with fever and
abdominal pain
Arcobacter sp. Recovered 2 weeks after
treatment
with ticarcillin-clavulanate
End-stage renal failure of
unknown cause
[25]
NS, not specified.
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Arcobacter spp. has been recently demonstrated [2,28], there-
fore, it is possible that the inclusion of more strains in the
BIOTYPER database will allow their correct identification, and
this will contribute to clarify the clinical importance of this
genus.
The seven housekeeping genes (aspA, atpA, glnA, gltA, glyA,
pgm and tkt) included in the Arcobacter multilocus sequence
typing database created by Miller et al. [29] were sequenced
from our isolate of A. cryaerophilus using the primers
described by these authors. New alleles were obtained for
four genes (i.e. aspA-215, atpA-152, gltA-149 and glyA-473),
while the sequences of the glnA (codifying for glutamine
synthetase), pgm (phosphoglucomutase) and tkt (transketo-
lase) genes corresponded to the already known alleles 59,
133 and 115, respectively. Therefore, this new clinical isolate
(strain 609) belonged to a new sequence type (ST) named
ST-392. Interestingly, the allele glnA-59 and the pgm-133 had
been obtained from strain 276, which was isolated from the
faeces of a patient with gastroenteritis in France in 2004,
while the allele tkt-115 had been obtained from strain 305,
which was also obtained from faeces of a patient with
gastroenteritis in the USA in 2009. Apart from strains 276
and 305, the database includes only two other isolates of
A. cryaerophilus recovered from human samples, i.e. strains
281 (from gastroenteritis) and 285 (from human blood), and
both isolates share the ST-201. The few available human
pathogenic strains in the database do not allow a relationship
to be established between the presence of certain alleles, or
STs, and virulence. Therefore, it is important that more
strains isolated from human infections are included in the
FIG. 1. Neighbour joining tree based on the concatenated sequences of aspA, atpA, glnA, gltA, glyA, pgm and tkt (3339 bp) showing the position of
strain 609 (ST-392) among the 75 strains of Arcobacter cryaerophilus included in the Arcobacter multilocus sequence typing database. Bootstrap values
(≥70%) based on 1000 replications are shown at the nodes.
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database as we did. In the tree constructed with the
concatenated sequences of the seven genes from each of
the 75 A. cryaerophilus strains that are currently included in
the database (Fig. 1), our strain grouped with two others
obtained in Europe from poultry (strain 346, ST-290 and
strain 325, ST-268), being therefore the most related strains.
However, whether the A. cryaerophilus strain was acquired in
our patient through consumption of poultry meat could not
be demonstrated.
Five putative Arcobacter virulence genes (ciaB, cadF, cj1349,
hecA and irgA) were also searched for in our strain using the
primers designed by Douidah et al. [30]. However, only the
presence of the ciaB gene was detected, which encodes for an
invasion protein in C. jejuni. The same result was obtained for
five strains of A. cryaerophilus recovered from shellfish and
from animal faeces in our laboratory [31]. In the study of
Douidah et al. [30], which included 99 A. cryaerophilus strains
isolated from human, chicken, pig, cattle, sheep, horse and dog,
the ciaB gene was present in the majority (92.9%) of the
strains, followed by cj1349 (51.5%), cadF (34.3%), hecA (4%)
and irgA (3%).
Among the faecal samples at theHospital Universitari Sant Joan
de Reus, where the isolate of A. cryaerophilus was obtained,
Campylobacter was the most commonly isolated enteropatho-
gen, representing 41.4% (65/157) of the positive stools in the last
year, followed by Salmonella spp. (36.3%), Aeromonas spp.
(14.6%), Shigella spp. (4.4%), Hafnia alvei (3.2%) and Yersinia
enterocolitica (1.3%). Among the Campylobacter and Campylobac-
ter-like organisms, C. jejuni was the most prevalent species
(82.7%), followed by Campylobacter coli (16.4%), while A. cry-
aerophilus was in third place (0.9%), which agrees with previous
studies [13,14].
A summarized revision of studies on Arcobacter, including
those comparing patients with and without diarrhoea, is
provided in Table 3. The prevalence of Arcobacter species in
human stools ranged from 0.1% to 1.25% in studies that derived
the information from culturing, whereas the detection from
faeces by PCR ranged from 0.4% to 13% [9,10,12–14,32–37]. In
one study, performed in Belgium and France where the
prevalence was determined by culture [13], A. butzleri occupied
the fourth place (3.5%) among Campylobacter-like organisms,
while A. cryaerophilus occupied the seventh place (0.5%). In
another study performed in South Africa using multiplex PCR
detection, A. butzleri showed a higher prevalence (6.2%) after
C. jejuni (10.2%) [10]. In the same study, A. cryaerophilus and
A. skirrowii showed lower incidences (2.8% and 1.9%, respec-
tively). In two other studies that detected Arcobacter using the
same multiplex PCR method a higher incidence was also
observed [12,38]. One was a case–control study of faeces from
diabetic patients in Italy [38]. In that study there was 78.9%
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on-diarrhoeic faeces of patients with type 2 diabetes, versus the
26.2% found for the controls (non-diabetic non-diarrhoea
subjects). In the second study, an 8.0% incidence was reported
among US/European travellers who suffered acute diarrhoea
while visiting Mexico, Guatemala and India [12]. Other recent
studies compared the ability to detect Arcobacter using in
parallel molecular and culture methods [36,37]. Collado et al.
[36] detected the species A. butzleri in 1.4% of stool samples of
patients with diarrhoea, using a genus-specific PCR and a
species-specific multiplex PCR method, whereas it was isolated
from only 0.7% of samples by culture. In the other study, de
Boer et al. [37] developed a multiplex real-time PCR able to
detect A. butzleri and campylobacters from the faeces of
patients with diarrhoea; testing this method in parallel with
culture. Using this method, A. butzleri was detected in 0.4% of
samples but was not recovered by culture. The higher
prevalence obtained using molecular methods supports the
statement that Arcobacter spp. could be underestimated as
enteropathogens because of limitations in the current culturing
methods, and demonstrates the importance of routinely
screening stool samples for the species of this genus using
molecular methods in parallel.
The isolation in our patient of A. cryaerophilus in the absence
of other enteropathogens and the remission of the diarrhoea
symptoms after treatment with amoxicillin/clavulanic acid, to
which the bacteria was sensitive, seems to indicate that this
bacterium could be considered the aetiological agent of the
diarrhoea process. Despite not being able to find the
contagious source of Arcobacter in the environment of our
patient, we were able to speculate that, in this case, it could
have been acquired through the consumption of poorly
cooked poultry meat or fish. Interestingly, the patient showed
recurrent episodes with abdominal pain, which seems to be a
typical clinical presentation for this genus.
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